ALFA Finder| Revenue growth | 22% YoY Q4 growth, primarily driven by strong volumes. |
|---|---|
| Margins | EBITDA margin maintained at 17.8% despite supply chain disruptions. |
| Demand visibility | Strong demand visibility for lithium salts and electrolyte formulations. |
| Management confidence | Balanced tone despite significant capex revisions and timeline delays. |
Growth
FY26 revenue grew 11% volume-led; Inorganic chemicals segment surged 145% on demand for lithium compounds.
Outlook
FY27 standalone revenue guided at ₹875-950cr; combined FY29 revenue potential of ₹3700-4200cr.
Risks
Battery capex revised upwards from ₹1500cr to ₹1800cr; persistent project delays risk liquidity strain.
Earnings Call filed with BSE, NSE: NEOGEN. Summary written with AI assistance from the document.
Neogen Chemicals Ltd: key numbers
- Share price
- ₹2,795.40
- Market cap
- ₹8,398 Cr
- Revenue (annual)
- ₹862.0 Cr
- Net profit (annual)
- ₹28.75 Cr
- P/E (TTM)
- 207.8×Sector 35.5×
- Promoter holding
- 48.31%-4.70% QoQ
- FII holding
- 4.13%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Neogen Chemicals Ltd
All →Neogen Chemicals Regulatory Approval
Neogen Chemicals received GPCB's revocation of its Dahej plant direction and a CC&A amendment for manufacturing. The revocation is for three months with conditions attached.
Neogen Chemicals Other Announcement
A HUF of a director of Neogen's wholly owned subsidiary sold 2,361 shares on 5-6 November 2026. Sale consideration totals about ₹0.59 crore.
- Value
- ₹0.59 Cr
Neogen Chemicals Annual General Meeting
Neogen Chemicals seeks shareholder approval via postal ballot for related party transactions with a step-down subsidiary. E-voting runs until December 6, 2026.
Neogen Chemicals Earnings Call Transcript: Key Takeaways
Revenue rose 42% to ₹296 Cr and consolidated PAT rose 144% to ₹8 Cr, but a large standalone-to-consolidated gap shows the Neogen Ionics drag. Net debt is ₹1,095 Cr, and management gave no hard quarterly target to test against.
Neogen Chemicals Investor Presentation: Key Takeaways
Q2 FY27 consolidated revenue INR 296 Cr (+42%), EBITDA INR 45 Cr (+51%), PAT INR 8 Cr (+144%). Battery Chemicals revenue INR 37 Cr; Organolithium capacity expansion approved.
Neogen Chemicals Results Update
Neogen Chemicals issued its Q2 FY27 press release on unaudited results, showing higher year-on-year revenue and profit. Battery chemicals ramp-up and the QIP proceeds featured prominently.